Back to Search
Start Over
Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits.
- Source :
-
Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2018 Feb; Vol. 30 (2), pp. 101-109. Date of Electronic Publication: 2017 Dec 06. - Publication Year :
- 2018
-
Abstract
- In spite of recent improvements in both the technical delivery of radiotherapy and systemic therapy in the treatment of non-small cell lung cancer, local recurrence rates after radiotherapy remain a significant challenge. In the setting of local relapse after radiotherapy, treatments such as surgical resection or radiofrequency ablation are often not appropriate owing to disease and patient factors. Re-irradiation may be a potential treatment option. This overview considers the published evidence and potential treatment strategies.<br /> (Copyright © 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1433-2981
- Volume :
- 30
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Clinical oncology (Royal College of Radiologists (Great Britain))
- Publication Type :
- Academic Journal
- Accession number :
- 29223641
- Full Text :
- https://doi.org/10.1016/j.clon.2017.11.003